Clinical Trial Update: Ketamine for Thrombolysis in Acute Ischemic Stroke [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial is investigating ketamine as an adjunct to thrombolysis in acute ischemic stroke; the status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Ketamine (ketamine)

Snippet

Sponsor: University Hospital, Caen | Conditions: Stroke | Phase 1, Phase 2 | Status: UNKNOWN